Stocks · US
COR
XNYS
Cencora, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E22.90x
P/B19.70x
P/S0.18x
EPS$13.75
ROE86.03%
ROA3.13%
Dividend yield0.78%
EV/EBITDA12.33x
Debt/Equity3.84
Free cash flow$4.1B
Returns and 52-week range
1W+2.85%
1M-4.41%
3M+2.20%
6M-1.41%
1Y+4.50%
YTD-6.64%
52W high$377.54
52W low$244.82
From 52W high-16.20%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Natera, Inc. Common Stock | $61.4B | — | 33.68 | +22.08% |
| Cardinal Health, Inc. | $54.0B | 31.49 | — | -5.56% |
| 보스턴 사이언티픽 | $61.4B | 16.72 | 2.46 | -11.74% |
| Edwards Lifesciences Corp | $50.3B | 50.03 | 4.74 | -3.80% |
| The Cigna Group | $71.7B | 11.17 | 1.68 | -2.88% |
| Becton, Dickinson and Co. | $49.2B | 52.30 | 2.02 | -2.40% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.